Related references
Note: Only part of the references are listed.Daily cannabis use: A novel risk factor of steatosis severity in patients with chronic hepatitis C
Christophe Hezode et al.
GASTROENTEROLOGY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species
Soeren V. Siegmund et al.
FASEB JOURNAL (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease
N. Mendez-Sanchez et al.
LIVER INTERNATIONAL (2007)
Endocannabinoids and the control of energy balance
Isabel Matias et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases
Ariane Mallat et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Fatima Teixeira-Clerc et al.
NATURE MEDICINE (2006)
The endocannabinoid system as an emerging target of pharmacotherapy
Pal Pacher et al.
PHARMACOLOGICAL REVIEWS (2006)
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats
SA Gaskari et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
C Hézode et al.
HEPATOLOGY (2005)
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cannabinoid-based drugs as anti-inflammatory therapeutics
TW Klein
NATURE REVIEWS IMMUNOLOGY (2005)
Antifibrogenic role of the cannabinoid receptor CB2 in the liver
B Julien et al.
GASTROENTEROLOGY (2005)
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
J Ros et al.
GASTROENTEROLOGY (2002)
Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis
S Bátkai et al.
NATURE MEDICINE (2001)
Share Paper
